NARA Discovery
Article Details
← Back to Search Results
Journal Article

A comprehensive review on schizophrenia: epidemiology, pathogenesis, diagnosis, conventional treatments, and proposed natural compounds used for management

Alaa Anwar; Aya M. Mustafa; Kareem Abdou; Mostafa A. Rabie; Riham A. El-Shiekh; Ahmed M. El-Dessouki
Naunyn-Schmiedeberg's Archives of Pharmacology · Vol. 398, Issue 11 · pp. 15231-15255 · 2025

Abstract

Schizophrenia (SCZ) is a complex, comprehensible mental condition that creates alienation from reality. SCZ is a mental disease, which is marked by progressive deficits in working memory, attention, and executive functioning. Because the disease’s etiology is unknown, current psychotherapy and pharmacological treatments merely treat symptoms and do not provide a cure. SCZ symptoms include hallucinations, delusions, disorganized behavior, and lack of desire. Long-term use of antipsychotic (antagonists at multiple G-protein-coupled receptors) (mGPCR antagonists) medicines for therapy has negative health consequences and discourages patients from taking regular medication. Ancient herbal therapies are regaining popularity in disease management due to their natural origins, less side effects, and cost-effectiveness. The various types of phytochemicals include alkaloids, glycosides, polyphenols, terpenes and terpenoids, phytosterols, cannabinoids, and carotenoids could be used as mGPCR antagonists. In this review, we documented the possibility of employing natural compounds as an alternative therapy to treat schizophrenia-related symptoms and cognitive impairments.

Bibliographic Information

JournalNaunyn-Schmiedeberg's Archives of Pharmacology
PublisherSpringer
Publication Date2025-11-01
Publication Year2025
Volume398
Issue11
Pages15231-15255
Document TypeJournal Article
Print ISSN0028-1298
eISSN1432-1912
DOI10.1007/s00210-025-04351-0

Access Information

NARA Access Coverage1873-01-01~Current
Journal Homepagehttps://www.springer.com/journal/210
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.